A study of primary care patients in 5 European countries found the mean antibiotic course duration for common respiratory ...
ALK (ALKB:DC / OMX: ALK B) today announced that the US Food and Drug Administration (FDA) has approved ALK's ODACTRA ® tablet for use in young children with house dust mite (HDM) allergy. ODACTRA ® is ...
Of children aged 5 to 10 years, about 40% had abnormal lung function post-treatment, rising to 65% in older children.
RSV infection that is managed via primary care in children under 5 years of age leads to a substantial burden for families, primary care resources, and society.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果